Japan, June 10 -- KAO CORP,EPSILON MOLECULAR ENGINEERING INC has got intellectual property rights for 'ANTI-SARS-COV-2 ANTIBODIES.' Other related details are as follows:

Application Number: JP,2022-024995

Category (FI): A61K39/395@S,A61P43/00,105,A61P31/14,A61P43/00,111,C07K16/104,G01N33/569@L,A61K39/395@N,C07K16/10,C12N15/13

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Feb. 21, 2022

Publication Date: Sept. 6, 2022

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.